Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study

Conclusion: This first in man study shows that tumor-targeted dual-modality imaging using 111In-DOTA-girentuximab-IRDye800CW is safe and can be used for intraoperative guidance of ccRCC resection.

Source: Theranostics - June 20, 2018 Category: Molecular Biology Authors: Marl è ne C. Hekman, Mark Rijpkema, Constantijn H. Muselaers, Egbert Oosterwijk, Christina A. Hulsbergen-Van de Kaa, Otto C. Boerman, Wim J. Oyen, Johan F. Langenhuijsen, Peter F. Mulders Tags: Research Paper Source Type: research